RSV Clinical Trials in Tampa, FL – Get Paid to Help Advance Respiratory Research
Protecting Patients. Advancing RSV Research. Improving Quality of Life.
Santos Research Center in Tampa is currently enrolling participants for clinical trials related to respiratory syncytial virus (RSV). Depending on the study, these trials may explore investigational vaccines, monoclonal antibodies, or other therapies focused on respiratory tract infections.
Study-related visits and exams with a physician are provided at no cost. Participants may also receive compensation for time and travel.
Now Enrolling – Respiratory Syncytial Virus (RSV) Clinical Trial
RSV is a common virus that affects the respiratory tract. It often causes mild symptoms like cough or fatigue, but in people with asthma, heart or lung disease, or a weakened immune system, it can lead to serious illness—such as lung inflammation, shortness of breath, or hospitalization.
Current RSV clinical research focuses on improving vaccine efficacy, developing monoclonal antibody therapies, and shaping public health strategies supported by the Centers for Disease Control and Prevention (CDC) and the European Medicines Agency.
Respiratory Syncytial Virus
Respiratory syncytial virus or RSV is a common infection that affects the respiratory tract.
RSV usually causes mild cold-like symptoms, but the virus can cause severe breathing problems.
Details
- Start Date: October 2022
- Phase: Phase 2
- Study Type: Interventional
- Insurance: No insurance is needed
- Benefits: Compensation up to $700 for time and travel
Eligibility
- The subject has a new onset of any of the following symptom(s) or worsening of preexisting symptom(s) consistent with a respiratory tract infection no more than 72 hours
- Body mass index ≥18 kg/m2 and ≤40 kg/m2
- Tested positive for RSV infection
Excluding
- An anticipated need for hospitalization within 24 hours
- Participant has end-stage renal disease
- Subject Has a SARS-CoV-2 test result that is positive within 28 days
- The subject has a history of chronic liver disease
Why Join an RSV Clinical Trial?
RSV clinical trials play a key role in improving vaccines, antibody therapies, and treatments for respiratory tract infections. Many studies test single-dose or booster dose vaccines, new injection types, and compare these options to current standards of care to assess immunity across age groups and health profiles.
Trials also explore how the immune system responds to different therapies in various age groups, including infants and older adults. Companies like Pfizer and Moderna are leading several of these vaccine trials, often using messenger RNA platforms or monoclonal antibodies like nirsevimab.
RSV can resemble the common cold, but in high-risk groups—such as those with asthma, immunodeficiency, or chronic disease—it may lead to serious illness. Your participation helps advance global health research and drug development for conditions that impact the lungs and overall breathing.
Benefits may include:
- » Access to investigational medicine under supervision of licensed health care providers
- » Study-related exams, health care, and monitoring at no cost
- » Compensation for your time and travel
- » A role in advancing immunology, public health, and clinical research
All trials are reviewed by an Institutional Review Board (IRB) and monitored by a data monitoring committee for safety, immune response, and potential side effects.
What to Expect
Pre-Screening Call
We’ll ask questions about your medical history, respiratory symptoms, and recent test results.
Clinic Visit
Meet with a physician, review informed consent, and complete an evaluation.
Treatment & Monitoring
If eligible, you’ll begin therapy and report symptoms like fever, headache, or cough. Our team tracks dose, reactogenicity, and immunogenicity as part of routine follow-up.
Why Patients Trust Santos Research Center
When you join a respiratory tract infection clinical trial at Santos Research Center, you’re partnering with one of Tampa’s most trusted and experienced clinical research facilities.
Join an RSV Clinical Trial in Tampa Today
Support ongoing RSV clinical research and gain access to investigational therapy and physician-led care. If you qualify, you may also receive compensation for your time and travel as part of your participation.
Why Participants Choose Us:
Also Enrolling at Santos Research Center
What Participants Say About Santos Research Center
Patients trust Santos Research Center for our compassionate care, professional staff, and clean, welcoming environment.
These testimonials reflect our ongoing commitment to putting patient safety, comfort, and quality of care first.
Frequently Asked Questions About RSV Clinical Research
The following answers provide general information about RSV clinical trials and current medical research. Specific eligibility, procedures, and risks vary by study and are fully explained during the informed consent process.
What is the goal of an RSV clinical trial?
RSV trials evaluate vaccine efficacy, antibody therapy, and immune system response to prevent or treat lower respiratory tract infection. Some trials also compare outcomes using placebo groups.
Are RSV vaccines approved?
Yes. Pfizer’s Abrysvo and Moderna’s mResvia are FDA-approved for adults over 60. Other trials study mRNA vaccines, booster dose responses, and attenuated vaccine models for infants.
Why are RSV vaccine trials in the news?
Some pediatric trials were paused due to safety concerns. A regulatory agency like the FDA and European Medicines Agency continues to assess safety data, with oversight from advisory committees.
What’s the difference between RSV and the flu?
RSV affects the respiratory tract, especially the bronchiole and lung. The influenza virus tends to cause full-body symptoms. Both viruses spread easily, but RSV is more dangerous for infants and seniors.
How is RSV diagnosed in a trial?
Most trials use reverse transcription polymerase chain reaction (RT-PCR) or antigen testing to confirm RSV before starting treatment. The specific method being used will be discussed with you during the informed consent process.
What groups are most at risk?
Those at highest risk for severe respiratory tract infection include infants, especially those born with preterm birth, and the elderly.
People with asthma, comorbidity, or a weakened immune system are also more likely to experience complications such as shortness of breath, hospitalization, or worsening lung function during infections like RSV or human metapneumovirus.
What treatments are being tested?
Current research explores monoclonal antibody (e.g., nirsevimab), combination vaccines, and new messenger RNA (mRNA) based therapy. Trials assess protein, neutralizing antibody, and antigen targets.
Is it safe to join?
All trials follow Food and Drug Administration -approved protocol and safety reviews from an Institutional Review Board. Some patients may experience fatigue, headache, or mild fever as side effects.
How is my information protected?
Your medical record is secured and shared only with authorized research staff and study sponsors. All data sharing complies with HIPAA and federal research guidelines.
Where can I learn more?
Check PubMed, GoogRSV is a highly contagious respiratory tract infection caused by a virus that can lead to serious disease, especially in infants and older adults.
Ongoing clinical research focuses on improving vaccine efficacy and reducing the health burden of RSV across high-risk populations.
Visit Scholar, ClinicalTrials.gov, or JAMA Network Open for the latest peer-reviewed studies, systematic reviews, and statistics from global sources like the New England Journal of Medicine and Crossref.
This page provides general information about RSV and clinical research. Details may vary by study. All procedures, risks, and eligibility will be reviewed with you during the informed consent process.
Glossary
1. Immunogenicity
How well a vaccine or treatment activates your immune system.
2. Reactogenicity
Mild side effects that can happen after a vaccine or medicine, like a fever or soreness.
3. Monoclonal antibody
Lab-made proteins that help your body fight viruses like RSV.
4. Reverse transcription polymerase chain reaction (RT-PCR)
A lab test used to detect viruses like RSV by looking at their genetic material.
5. Placebo
A harmless, inactive substance used to compare results in a trial. It helps researchers see if a treatment really works.
To learn more about the specific RSV study currently enrolling at Santos Research Center, please review the study details above or contact our research team at (813) 249-9100.